Detalhe da pesquisa
1.
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer.
Clin Cancer Res
; 12(20 Pt 1): 6106-15, 2006 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17062687
2.
Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma.
Clin Cancer Res
; 12(8): 2526-37, 2006 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16638862
3.
Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer.
J Clin Oncol
; 21(16): 3127-32, 2003 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12915604
4.
Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma.
Clin Cancer Res
; 9(8): 2973-80, 2003 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12912944
5.
Cancer regression in patients after transfer of genetically engineered lymphocytes.
Science
; 314(5796): 126-9, 2006 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-16946036
6.
Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma.
J Immunother
; 28(6): 582-92, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16224276
7.
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.
Science
; 298(5594): 850-4, 2002 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-12242449
8.
A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma.
J Immunother
; 25(3): 243-51, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12000866